IP Verse

Develco Pharma competitive analysis

Loading summary...

Explore patent oppositions filed by Develco Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 30, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3578173	Dosage Form Containing Oxycodone And Naloxone	EURO CELTIQUE	Oct 26, 2022
EP2694049	Tapentadol For Preventing Chronification Of Pain	GRNENTHAL	Jan 13, 2021
EP3024461	A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation	EURO CELTIQUE	May 14, 2020
EP2962686	Dosage Form Containing Oxycodone And Naloxone	EURO CELTIQUE	Apr 11, 2019
EP2425821	Pharmaceutical Preparation Containing Oxycodone And Naloxone	EURO CELTIQUE	May 11, 2017
EP2425824	Pharmaceutical Preparation Containing Oxycodone And Naloxone	EURO CELTIQUE	May 11, 2017

Explore the latest publications and patents granted to Develco Pharma, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Develco Pharma, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Develco Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
DEVELCO PHARMA SCHWEIZ	5	-	-	-
EURO CELTIQUE	-	44	-	-
MUNDIPHARMA	-	25	-	-
NAPP PHARMACEUTICAL	-	25	-	-